CDC42 and central nervous system cancer: CDC42 knockdown or treatment with the CDC42 specific inhibitor ZCL278 [29] reversed the enhanced migration and invasion abilities of glioma cells under TRIM56 overexpression in U87, U251 and LN229 cells (Fig. 5C, D and Supplementary Fig. 6A).